Showing results (1421-1430 of 2,777) with videos related to

Sort By:
Pageof 278
Clinical and Experimental Nephrology|October 31, 2024
Recovery time is associated with the onset of cardiovascular disease in Japanese patients undergoing maintenance hemodialysisTakaaki Nawano, Kazunobu Ichikawa, Tsuneo Konta, et al.
Clinical and Experimental Nephrology|November 18, 2025
Proteinuria reduction as a surrogate endpoint for clinical study of IgA nephropathy in Japanese patients: data from the J-CKD-DB-ExNaoki Kashihara, Seiji Itano, Takaya Nakashima, et al.
Clinical and Experimental Nephrology|November 2, 2025
Diagnosis and treatment in adult patients with C3 glomerulopathy in Japan: a real-world surveyNaoki Nakagawa, Yutaro Kotobuki, Michel Kroes, et al.
Clinical and Experimental Nephrology|September 25, 2025
ABO-incompatible living-donor kidney transplantation is not associated with post-transplant malignancy: a multicenter retrospective studyTakaaki Nawano, Hayato Nishida, Kazunobu Ichikawa, et al.
Clinical and Experimental Nephrology|January 1, 2020
Clinical pharmacological study of dotinurad administered to male and female elderly or young subjectsHiroshi Nakatani, Masahiko Fushimi, Tomomitsu Sasaki, et al.
Clinical and Experimental Nephrology|December 27, 2019
Effect of renin-angiotensin system blockade on graft survival and cardiovascular disease in kidney transplant recipients: retrospective multicenter study in JapanAkihiro Tsuchimoto, Kosuke Masutani, Kenji Ueki, et al.
Clinical and Experimental Nephrology|December 27, 2019
The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trialYoshihiro Kuwabara, Shinji Yasuno, Masato Kasahara, et al.
Clinical and Experimental Nephrology|December 18, 2019
The impact of tonsillectomy combined with steroid pulse therapy in patients with advanced IgA nephropathy and impaired renal functionSaeko Kumon, Takahito Moriyama, Takahiro Kamiyama, et al.
Clinical and Experimental Nephrology|December 18, 2019
Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemiaHiroshi Matsuo, Eiji Ishikawa, Hirofumi Machida, et al.
Clinical and Experimental Nephrology|December 12, 2019
Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad: a novel selective urate reabsorption inhibitorHiroyuki Fukase, Daisuke Okui, Tomomitsu Sasaki, et al.
Pageof 278